131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study

被引：0
|
作者：
Chien-Mu Lin
Pat Doyle
Yu-Tse Tsan
Chang-Hsing Lee
Jung-Der Wang
Pau-Chung Chen
机构：
[1] Taipei Medical University – Shuang Ho Hospital,Department of Nuclear Medicine
[2] Taipei Medical University,Department of Radiology, College of Medicine
[3] London School of Hygiene and Tropical Medicine,Faculty of Epidemiology and Population Health
[4] National Taiwan University College of Public Health,Institute of Occupational Medicine and Industrial Hygiene
[5] Taichung Veterans General Hospital,Department of Emergency Medicine
[6] Chung Shan Medical University,School of Medicine
[7] Ton Yen General Hospital,Department of Occupational Medicine
[8] National Cheng Kung University College of Medicine,Department of Public Health
[9] National Taiwan University College of Public Health,Department of Public Health
[10] National Taiwan University College of Medicine and Hospital,Department of Environmental and Occupational Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
Hyperparathyroidism, primary; Iodine radioisotopes; Thyroid neoplasms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：253 / 259
页数：6
相关论文
共 50 条
  • [1] 131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study
    Lin, Chien-Mu
    Doyle, Pat
    Tsan, Yu-Tse
    Lee, Chang-Hsing
    Wang, Jung-Der
    Chen, Pau-Chung
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 253 - 259
  • [2] 131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study
    Ko, Kuan-Yin
    Kao, Chia-Hung
    Lin, Cheng-Li
    Huang, Wen-Sheng
    Yen, Ruoh-Fang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (08) : 1172 - 1178
  • [3] 131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study
    Kuan-Yin Ko
    Chia-Hung Kao
    Cheng-Li Lin
    Wen-Sheng Huang
    Ruoh-Fang Yen
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1172 - 1178
  • [4] Thyroid cancer risk after thyroid examination with 131I:: A population-based cohort study in Sweden
    Dickman, PW
    Holm, LE
    Lundell, G
    Boice, JD
    Hall, P
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) : 580 - 587
  • [5] Association Between 131I Treatment for Thyroid Cancer and Risk of Receiving Cataract Surgery: A Cohort Study from Taiwan
    Lin, Chien-Mu
    Yeh, Po-Ting
    Doyley, Pat
    Tsan, Yu-Tse
    Chen, Pau-Chung
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 836 - 841
  • [6] Cancer Risk in Graves Disease with Radioactive 131I Treatment: A Nationwide Cohort Study
    Kim, Kyeong Jin
    Choi, Jimi
    Kim, Kyoung Jin
    Song, Eyun
    Yu, Ji Hee
    Kim, Nam Hoon
    Yoo, Hye Jin
    Seo, Ji A.
    Kim, Nan Hee
    Choi, Kyung Mook
    Baik, Sei Hyun
    Kim, Sin Gon
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (05) : 693 - 699
  • [7] Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study
    Lin, Chun-Yi
    Lin, Cheng-Li
    Huang, Wen-Sheng
    Kao, Chia-Hung
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (05) : 685 - 690
  • [8] Association between I-131 treatment for thyroid cancer and risk of developing second primary malignancy_a cohort study from Taiwan
    Lin, C.
    Doyle, P.
    Tsan, Y.
    Chen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S292 - S292
  • [9] Risk of thyroid cancer after exposure to 131I in childhood
    Cardis, E
    Kesminiene, A
    Ivanov, V
    Malakhova, I
    Shibata, Y
    Khrouch, V
    Drozdovitch, V
    Maceika, E
    Zvonova, I
    Vlassov, O
    Bouville, A
    Goulko, G
    Hoshi, M
    Abrosimov, A
    Anoshko, J
    Astakhova, L
    Chekin, S
    Demidchik, E
    Galanti, R
    Ito, M
    Korobova, E
    Lushnikov, E
    Maksioutov, MA
    Masyakin, V
    Nerovnia, A
    Parshin, V
    Parshkov, E
    Piliptsevich, N
    Pinchera, A
    Polyakov, S
    Shabeka, N
    Suonio, E
    Tenet, V
    Tsyb, A
    Yamashita, S
    Williams, D
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (10): : 724 - 732
  • [10] Role of 131I in the treatment of well differentiated thyroid cancer
    Woodrum, DT
    Gauger, PG
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 89 (03) : 114 - 121
12345